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Abstract
Harmonization of acquisition and analysis protocols is an important step in the validation of BOLD MRI as a renal biomarker. 
This harmonization initiative provides technical recommendations based on a consensus report with the aim to move towards 
standardized protocols that facilitate clinical translation and comparison of data across sites. We used a recently published 
systematic review paper, which included a detailed summary of renal BOLD MRI technical parameters and areas of inves-
tigation in its supplementary material, as the starting point in developing the survey questionnaires for seeking consensus. 
Survey data were collected via the Delphi consensus process from 24 researchers on renal BOLD MRI exam preparation, 
data acquisition, data analysis, and interpretation. Consensus was defined as ≥ 75% unanimity in response. Among 31 survey 
questions, 14 achieved consensus resolution, 12 showed clear respondent preference (65–74% agreement), and 5 showed 
equal (50/50%) split in opinion among respondents. Recommendations for subject preparation, data acquisition, processing 
and reporting are given based on the survey results and review of the literature. These technical recommendations are aimed 
towards increased inter-site harmonization, a first step towards standardization of renal BOLD MRI protocols across sites. 
We expect this to be an iterative process updated dynamically based on progress in the field.
Keywords BOLD MRI · Kidney · Imaging · Biomarkers · Standardization · Consensus
Introduction
Blood oxygenation level dependent (BOLD) MRI, as the 
name suggests, is an MRI contrast mechanism that depends 
on the oxygenation status of blood, specifically the oxygena-
tion of blood hemoglobin (Hb) [1]. Oxygen saturation of 
Hb changes the magnetic properties of the Hb from being 
diamagnetic when fully oxygenated to paramagnetic in its 
deoxygenated state, which shortens the observed transverse 
free induction decay time constant, T2*, or lengthens the 
corresponding rate constant R2* = 1/T2*. Thus, a change in 
the ratio of oxy- to deoxy-Hb in blood results in a measur-
able change on BOLD MRI contrast and is widely used in 
functional MRI of the brain [2]. Since the ratio of oxy- to 
deoxy-Hb is a major determinant of blood partial pressure 
of oxygen  (PO2), the method in principle can be used to 
measure an index of blood  PO2. If one assumes that blood 
 PO2 is in a dynamic equilibrium with the surrounding tissue 
 PO2, then the BOLD MRI measurements can reflect tissue 
 PO2. To reflect these underlying assumptions about the bio-
distribution of  PO2, the BOLD MRI T2* or R2* measure is 
sometimes referred to as “oxygen availability”. The method 
is completely non-invasive, since it utilizes an endogenous 
contrast mechanism and does not require injection of any 
exogenous contrast agent.
In contrast to virtually all other organs in the body, in the 
healthy kidney, not only the supply of oxygen, but also oxy-
gen consumption is determined by blood flow [3]. The major 
determinant of oxygen consumption in the kidneys is sodium 
reabsorption. The amount of sodium to be reabsorbed is pro-
portional to the glomerular filtration rate (GFR) which in 
turn, in general, changes in parallel with renal blood flow. 
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Since both oxygen supply and demand are related to renal 
blood flow, evaluating renal oxygen status independent of 
perfusion is necessary in the kidneys. Much of the early 
data on renal oxygenation was obtained in animal models 
using invasive probes which have documented a gradient of 
decreasing oxygenation from cortex to inner medulla [4]. 
However, due to the lack of a non-invasive method for use 
in humans, very little was known about whether human kid-
neys have the same anatomical variations in oxygenation as 
observed in rodents. With the availability of BOLD MRI the 
presence of such a gradient was verified in the kidneys of 
healthy subjects [5]. Much of the early literature on BOLD 
MRI focused on the medulla, a region of naturally low oxy-
gen tension. Since this region is known to be at risk for 
ischemic injury, understanding the endogenous mechanisms 
that maintain oxygenation status and effects of exogenous 
maneuvers that can modulate the oxygenation status were 
foci of early studies [6–10].
An early application of the BOLD MRI method to clinical 
studies was in renal artery stenosis where it was important to 
know who may benefit from re-vascularization [11]. Based 
on earlier reports in rodent models of diabetes [12, 13], there 
have also been studies assessing the relative oxygen status in 
individuals with diabetes and varying levels of renal func-
tion [14, 15]. With gaining interest in the chronic hypoxia 
hypothesis related to progressive chronic kidney disease 
(CKD) [16], there has been growing interest in evaluating 
renal oxygenation status in CKD [17–19] and kidney trans-
plant [20–23]. This evolution towards clinical translation has 
led to the realization of the importance of standardization or 
harmonization of subject preparation, data acquisition and 
analysis methods. Without harmonization, it is currently 
difficult to objectively compare BOLD T2* (R2*) measures 
between sites and this constitutes a barrier for multi-center 
studies and pooling of clinically relevant data to inform 
future practice.
All physiological and functional imaging methods are 
inherently dependent on the physiological status of the organ 
at the time of data acquisition. To be able to compare data 
from one individual to another it is important to standardize 
the baseline physiological status (to the best extent possible). 
Water intake or hydration status has been shown to signifi-
cantly influence renal oxygenation [6] as does salt intake [9]. 
Since consumption of food inherently involves consumption 
of water, fasting prior to the BOLD MRI study (e.g. 4 h) is 
commonly used. Controlling salt intake requires more regi-
mented protocols and it is not practical to implement for 
routine clinical use.
While early studies used single-shot echo planar imaging 
(EPI) sequences for renal BOLD MRI [5], the most widely 
used current method is the multiple gradient echo (mGRE) 
(Fig. 1a) acquisition [24, 25]. Typically 8–16 gradient echo 
images (Fig. 1) are acquired during breath-holds and a 
mono-exponential fit of the signal intensity with respect to 
echo time is used to estimate the relaxation time constant 
T2*. The sequence is widely available on all major vendor 
platforms and it typically comes with the option to calculate 
T2* or R2* online. While this has facilitated the widespread 
utility of the method, variations in the specific acquisition 
parameters make the comparison of data across sites diffi-
cult. Similarly, the subjective definition of manually defined 
Fig. 1  a Pulse sequence diagram of a multiple gradient-echo (mGRE) 
sequence with n echo times  (TE1–TEn) obtained from a single RF 
excitation, with the readout gradient (Gread) rewinded after each sig-
nal sampling (ACQ). b BOLD-MRI acquisition (breath hold, 2D 
mGRE sequence, TR = 51 ms, flip angle = 30°, 5 mm slice thickness, 
5 mm space between slices, FOV 400 × 400 mm, matrix 256 × 256) 
example with eight echo times (TE from 3.09 to 30.53 ms, bandwidth 
256  Hz/pixel); cortex and medulla ROI delineation example, and 
R2* grayscale map on a 3T Siemens  Skyrafit in a healthy volunteer 
(female, age 64, BMI 25.6). (Courtesy: Lu-Ping Li, Ph.D., North-
Shore University Health System, Evanston, IL, USA). BOLD blood-
oxygen level dependent, FOV field of view, mGRE multi-echo gradi-
ent echo, RF radio frequency, ROI region of interest, TE echo time
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regions of interest (ROIs) is widely reported and leads to an 
additional source of bias and variability, especially when 
related to the renal medulla (Fig. 1b). This problem of sub-
jectivity is further aggravated in diseased kidneys since 
loss of cortico-medullary contrast is a hallmark in several 
forms of renal disease [26], including CKD. This has led to 
proposals to perform whole kidney analysis where the user 
only needs to manually trace the outer boundaries of renal 
parenchyma [19, 27, 28].
The objective for this initiative is to provide technical 
recommendations for renal BOLD MRI based on a consen-
sus between experts in the field, aiming to promote a more 
standardized approach that will facilitate comparison of 
data across sites. We used a recently published statement 
paper [29], which included a detailed summary of param-
eters in their supplementary material, as the starting point 
to identify topics of interest in developing the question-
naires for seeking consensus. The work was facilitated by 
the ‘PARENCHIMA’ initiative “MRI Biomarkers for CKD” 
(CA16103), a community-driven Action of the European 
Cooperation in Science and Technology (COST) program of 
the European Union, which aims to improve the reproduc-
ibility and standardization of renal MRI biomarkers.
Materials and methods
Description of the survey process
During the PARENCHIMA Annual Plenary Meeting in 
Prague (October 4–5th 2018), the Task Force on Technical 
Recommendations for Clinical Renal MRI decided to follow 
a modified Delphi method [30–32] for seeking consensus 
regarding technical BOLD MRI acquisition and analysis. 
The Delphi method derives consensus recommendations 
through qualitative evaluation of published studies by 
experts. Where published data is scarce, experts can make 
inferences based on data from similar contexts, or their own 
experiences. Published evidence is summarized in the form 
of a questionnaire. Participants are invited to respond to 
the questionnaire in several rounds (typically 3), reviewing 
an anonymous summary of the previous responses before 
responding to the subsequent rounds. Respondents are asked 
to indicate whether they consider themselves sufficiently 
knowledgeable to answer each of the questions. Consensus 
on a question is usually defined as 68%-80% unanimity in 
responses [31–33]. Discussion in a face-to-face meeting 
between all respondents usually follows one or several of 
the rounds, and serves to build consensus in the areas where 
prior responses failed to achieve consensus. Owing to wide 
geographic distribution of the experts and respondents, we 
have adopted a modified Delphi method for this project with 
only a single face-to-face meeting before the final round of 
surveys.
Construction of the questionnaire
The questionnaires were constructed by the panel co-chairs 
(PVP, OB and SF), between February 2019 and April 2019, 
and administered online to participants in two rounds via an 
online form (Google Forms, https ://docs.googl e.com/forms ). 
In constructing the questionnaires, the co-chairs used a 
recently published PARENCHIMA statement paper [29] and 
its detailed summary of parameters in the supplementary mate-
rial, to formulate questions on renal BOLD MRI research top-
ics, technical image acquisition parameters and analysis meth-
ods. Round 1 consisted of 35 questions with multiple-choice 
responses, with the possibility to abstain or to provide a long 
form answer. Participants were prompted to explain the reason-
ing behind their choices in a comment section following each 
item, and also to suggest questions for inclusion in Round 2 of 
the questionnaire.
Six members of the panel attended a face-to-face meet-
ing between March 18th–19th 2019 at Aarhus University 
Hospital, Denmark. Based on a review of the first round 
of questionnaire responses, they worked together on addi-
tional questions and on the wording for specific questions 
in Round 2. Round 2 consisted of 31 items with answers in 
simplified multiple-choice format (“I agree”, “I disagree”, 
“I have insufficient experience to make a recommendation”) 
and possibility to explain the choice in a comment section 
following each item. Questions that reached consensus in 
Round 1 were summarized to the respondents in Round 2, 
and respondents were offered opportunity to comment if 
they did not agree. Respondents were encouraged to answer 
the questionnaire based on published evidence (some items 
pointed to specific publications) and best practices as 
reflected in the literature, not necessarily on their current 
research practice. Both iterations of the questionnaire had 
items grouped under four themes: (1) patient preparation 
(common items among all PARENCHIMA task force panels 
for Round 2, see covering review paper); (2) acquisition; (3) 
analysis; (4) application and interpretation.
Panel selection
The first panel consisted of 10 PARENCHIMA task force 
members with a publication record and research interest in 
BOLD MRI. To expand our pool of respondents for the 2nd 
round, we invited other experts outside of our collaboration. 
We identified renal BOLD experts on the basis of a PUB-
MED literature search using [BOLD MRI] AND [kidney] 
AND [human]. An additional 16 respondents were enrolled 
while two respondents to the first questionnaire did not par-
ticipate in the second one. For the second and final round of 
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the questionnaire, we had 24 respondents from 22 academic 
institutions, 9 countries and 3 continents. All respondents 
are listed as authors of this manuscript. Panelists were asked 
to list their specialty when responding to the questionnaire.
Interpretation of the survey results
At the Aarhus meeting, a “traffic light” system was adopted 
to issue recommendations based on the degree of consensus 
achieved through the questionnaire. Green light (consensus, 
closed issues) on a topic was defined as at least 75% una-
nimity in responses to a question. An “orange light” was 
defined in the case where the responses showed clear opin-
ions (65–74%), but did not meet the threshold. For a “red 
light” topic, the questionnaire showed no clear expert prefer-
ence (50–64%), so that no recommendation is possible with 
the information given to the respondents. It was also agreed 
that when calculating percentage of responses, the “abstain” 
responses (i.e. “I have insufficient experience to make a rec-
ommendation”) will be excluded. However, the percentage 
of “abstain” responses for each item will be reported, to 
reflect the level of familiarity of the experts with the topic 
and to show the topic’s importance (or lack thereof) in the 
clinical renal BOLD MRI community.
Results
Results of survey
The final results of the survey are summarized for each area 
in Tables 1, 2, 3, 4, 5, 6 and 7. For the second and final 
round of the survey, physicists (MR physicists or biomedi-
cal engineers) and clinicians (radiologists, nephrologists 
or physiologists) were equally represented (Table 2). The 
panelists reached consensus on 14 out of 31 items (45%) 
(Tables 3, 4, 5, 6). Additionally, panelists concurred on the 
nine questions for which consensus was achieved in Round 1 
(Table 7). 12 items met the “orange light” definition, show-
ing a clear direction of respondents’ opinions, while 5 items 
were “red light” topics with a 50/50% split in respondents’ 
opinions. Even though the overall response did not reach the 
75% threshold, some questions had responses that reached 
the threshold in one of the sub-group analysis, Physicists or 
Clinicians. The presentation of responses by sub-group may 
Table 1  Final recommendations 
on renal BOLD MRI data 
acquisition, analysis and 
interpretation
Entries in bold font are based on the consensus process
Bold blood-oxygen level dependent, ROI region of interest, T2* transverse free-induction decay time, TE 
echo time
BOLD MRI
Preparation Normal hydration (100 ml water), 4 h fasting from food
Field strength 1.5 T or 3.0 T, 3T preferred if available
Sequence 2D mGRE
Orientation Coronal oblique to kidneys
In-plane resolution 2–3 mm
Slice thickness 3–5 mm
Coverage 3–5 slices centered on renal hilum
Parallel imaging factor 2
Fat suppression Yes
TR (s) 60–75 ms
TE (ms) 8–16 echoes, up to 50 ms (~T2* cortex) at 3T with 
choice of in phase for fat-water
Averages 1
Breathing mode Breath hold
Image quality control Recommended
ROI placement Manual
Cortical ROI 1 stripe/slice; > 3 slices
Medullary ROI 3 samples/slice; > 3 slices
Fitting Monoexponential or log-linear
Reporting Cortex and medulla
Reported metric R2* (s−1)
Metric statistics reporting Mean, median, standard deviation, ROI size
Map format Color or grayscale quantitative map
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be useful for our readers to draw perspectives, and so we 
have included sub-group results in all our tables.
Final recommendations
Our final recommendations, summarized in Table 1, are 
based on the literature, the consensus views and opinion 
trends that emerged from the survey and the face-to-face 
meeting.
• Regarding patient preparation, irrespective of the level 
of consensus reached, users should consider ways of nor-
malizing the baseline physiological status. Even though 
data exists only for hydration status, food intake com-
monly is associated with fluid intake and a likely con-
founding factor. When feasible, fasting for 4 h may be 
a good option. A related issue of bowel gas has not yet 
been fully resolved in terms of minimizing its presence.
• Even though the choice of 3T did not reach the 75% 
threshold, there is a general acceptance that, if given a 
choice between the field strengths, 3T is preferable. In 
the absence of access to 3T, 1.5T remains an adequate 
choice. While there is a concern for increased magnetic 
field inhomogeneities at 3T, there is considerable expe-
rience to-date that supports the higher sensitivity and 
signal-to-noise ratio (SNR) afforded by 3T, making it a 
preferred choice.
• Magnetic field inhomogeneities (e.g. due to poor shim-
ming, presence of metal or air interfaces) play an impor-
tant role and should be minimized. These will affect the 
measured R2* values and results in a voxel-size depend-
ence of R2*. Slice thickness is the largest contributor to 
voxel size, and has the largest contribution to the voxel-
size dependence of R2* due to through-slice dephasing 
although the effects may be lower in the coronal orienta-
tion. While smaller and isotropic voxels are preferred, 
they are limited by the need for breath-holding. Adopting 
a fixed voxel size for all studies may be a preferred way 
to standardize the protocol and allow comparisons across 
sites. This is challenging to implement in routine prac-
tice because voxel size can be set directly on the scan-
ners of one vendor (e.g. Philips), while in other vendors’ 
scanners (e.g. Siemens, GE) the voxel size is derived 
from field of view (FOV) and matrix size. Even if matrix 
size is kept constant, MRI technologists are inclined to 
change FOV based on the body habitus. Thus, standard 
operating procedures (SOPs) are necessary and the MRI 
technologist needs to be instructed not to change the FOV 
when prescribing renal BOLD MRI.
• The presence of fat may have an effect on measured 
R2* values, and use of fat saturation or water-excitation 
pulses is preferred.
• Most studies to-date have focused on the renal medulla 
which has a higher R2* (~30 s−1 at 3T) and hence a 
shorter T2* (~33 ms). In comparison, the renal cortex 
has R2* ~20 s−1 at 3T and T2*~50 ms. After fixing the 
longest TE = 50 ms, investigators need to decide the num-
ber of echo times. For a robust acquisition, any number 
of echoes between 8 and 16 would be acceptable. The 
actual number of echoes that is realizable will depend on 
readout bandwidth, echo spacing and image resolution. 
The bandwidth should be kept to around 300 Hz/pixel. 
With this echo time, use of either a mono-exponential or 
log-linear fit would be acceptable since the noise floor 
will not be reached.
• R2* was the preferred metric and there was consensus 
for evaluating both cortical and medullary regions. ROI 
analysis was preferred, only because of widespread avail-
Table 2  Panel characteristics
The co-chairs sought equal representation of MR physicist and clinician researchers involved in BOLD MRI
a 1 radiologist was also a Ph.D. physicist; 1 nephrologist was also a PhD physiologist
Respondents for Round 1 n = 10 Percentage
Physicists 7 70
Clinicians 3 30
Radiologists 1 10
Nephrologists 2 20
Physiologistsa 1 10
Respondents for Round 2 n = 24 Percentage
Physicists 12 (50%) 50
Clinicians/physiologists 13 (50%) 54
Radiologistsa 11 46
Nephrologists 2 8
Physiologistsa 1 4
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ability. While newer custom methods have advantages 
such as better objectivity, these also have several limita-
tions. Until automated segmentation becomes routinely 
available, manual segmentation may be preferred.
• There was an agreement that BOLD MRI provides a 
qualitative measure of relative oxygen availability and 
may be most suited for evaluating acute changes within 
the same kidney, e.g. following administration of furo-
semide. However, caution was advised when compar-
ing different cohorts because of potential confounding 
effects such as blood volume fraction, oxy-Hb dissocia-
tion curve, and haematocrit [34]. Even though there was 
consensus in terms of reproducibility at a single site, 
similar data for multi-site studies remains lacking, and 
is thus desirable for future studies.
• Similar recommendations are made for BOLD in native 
kidneys and allografts. However, the allografts’ position-
ing in the iliac fossa, closer to the skin during an end-
expiration breath-hold, sometimes requires different miti-
gation strategies for the tissue-air interface susceptibility 
artefacts (e.g. placing a bag of saline on the skin over the 
expected region of the allograft before placing the imag-
ing coil on the subject). Planning of slices in true coronal 
(to the allograft) orientation is somewhat more difficult 
than with native kidneys and in some studies an oblique 
sagittal slice with respect to the allograft’ longitudinal 
axis is preferred.
Discussion
Patient preparation
Three identical items on patient preparation prior to the 
MRI scan (Table 3) were included in all PARENCHIMA 
panels’ questionnaires on clinical renal MRI. To-date, these 
questions are most relevant for the BOLD MRI panel. A 
previous systematic review conducted by PARENCHIMA 
[29] showed that of 20 studies on drug and dietary effects 
on renal BOLD MRI, 12 studies required their subjects to 
abstain from food and water for 12 h before MRI, with (8 
studies) and without (4 studies) subsequent water loading, 1 
study had a shorter fasting period of 2 h before MRI, and 7 
studies did not require fasting. The variety of patient prepa-
ration in published studies was reflected in the responses to 
our survey. The respondents did not reach consensus on the 
need to control subjects’ diet before the scan, although 82% 
of clinicians were in favor of controlling the diet. Respond-
ents’ comments to the question may explain the lack of 
consensus:
• 25% of respondents disagreed that diet should be con-
trolled,Ta
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Table 7  Survey items from Round 1 which achieved consensus, excluding abstain (“Do not know”) and “Other” answers
These items and the dominant response percentages were shown to participants in Round 2, who concurred to the consensus in Round 1
Bold blood-oxygen level dependent, TE echo time
Overall (%)
1.5T is acceptable for obtaining quality BOLD data. [choose a single option]
 Agree (comment in other) 100
 Disagree (comment in other) 0
 Do not know 30
 Other 0
The smallest bandwidth should be chosen for the selected maximum TE
 Agree (comment in other) 83
 Disagree (comment in other) 16
 Do not know 30
 Other 10
Do number of echoes and/or spacing between TE’s have an effect on data quality?
 Agree (comment in other) 88
 Disagree (comment in other) 12
 Do not know 20
 Other 12.5
Is breath-holding the best approach for controlling motion in renal BOLD MRI?
 Yes 80
 No 20
 Do not know 0
 Other 0
Is analysis of cortex and medulla important?
 Yes, both equally important 90
 Cortex is more important than medulla (comment in other) 0
 Medulla is more important than cortex (comment in other) 10
 Do not know 0
 Other 0
Is renal BOLD MRI potentially a prognostic technique?
 Yes 100
 No 0
 Do not know 20
 Other 0
Does renal BOLD MRI reflect intra-renal oxygenation (qualitatively or quantitatively)?
 Yes, BOLD MRI can quantify intrarenal oxygenation 20
 Yes, qualitatively, there are too many confounding factors for it to be quantitative 80
 No, it does not 0
 Do not know 0
 Other 0
From existing data, do you believe renal BOLD MRI is more suited to detect changes in renal oxygenation within the same kidney rather than 
comparing cohorts?
 Yes, best used to detect changes within the same kidney, due to confounding effects of blood volume and hematocrit that are different between 
patients
88
 It is suitable to compare cohorts without adjustments for patients’ blood volume and hematocrit 0
 It is suitable to compare cohorts with adjustment for patients’ blood volume and hematocrit 11
 Do not know 10
 Other 0
Does the furosemide stress test/ physiological challenge have value?
 Yes, always 25
 Yes, but it may not be necessary or suitable for some applications (comment in Other) 75
 No (comment in Other) 0
 Do not know 20
 Other 0
209Magnetic Resonance Materials in Physics, Biology and Medicine (2020) 33:199–215 
1 3
• 4% cited lack of publications showing an effect of diet on 
BOLD signal, and
• 4% thought that monitoring and reporting subjects’ diet 
is sufficient.
• 12.5% of respondents recommended fasting (water only 
intake) for 4–6 h before the scan, 8% went further and 
recommended abstaining from high protein foods 24 h 
before the scan in addition to fasting, to minimize sus-
ceptibility artifacts from bowel gas.
• Another 8% of respondents thought restricting drinking 
before the scan can reduce artifacts from the bowel, and 
can have an effect on BOLD quality.
• Another 8% of respondents recommended controlling 
sodium intake, possibly through standardized meals for 
study subjects in prospective studies.
The respondents reached consensus (87%) that patients 
should be scanned in a normal (i.e. not restricted to water 
intake) hydration status, based on studies that show the influ-
ence of hydration status on BOLD signal (as mentioned by 
8% of respondents). Respondents agreed that hydration sta-
tus should be controlled, through fasting (4%) or standard-
ized (i.e. all subjects treated similarly in terms of hydration 
[35]) intake of water (8%).
There was no consensus that sodium intake should be 
standardized before the scan. 65% of respondents tended 
to disagree. Even though disagreement among physicists 
reached consensus threshold (75%), there was a split opin-
ion among clinicians (agree/disagree: 44%/56%). Eight per-
cent of the respondents mentioned their awareness of studies 
showing that salt intake influences BOLD measurements, 
with the caveat that the influence of sodium and hydration on 
the BOLD signal is smaller in the cortex than in the medulla. 
Modifying salt intake also influences kidney physiology, and 
may thus confound studies looking at subjects’ typical renal 
physiology, as commented by another 8% of respondents. 
12.5% of respondents motivated their disagreement to this 
item by the practical difficulties of controlling subjects’ 
sodium intake, as salt is found in most processed foods. 8% 
of respondents recommended that controlled sodium intake 
is feasible for in-patient subjects who can follow a stand-
ardized diet during their hospital stay. While standardizing 
salt intake is not possible or suitable for the study design, 
monitoring and recording salt intake (e.g. via food diaries) 
by the subjects can add to any one study’s rigor.
Data acquisition
The results of the survey items on data acquisition are sum-
marized in Tables 4 and 7. We sought expert opinion on 
aspects of BOLD MRI data acquisition protocol includ-
ing choice of field strength, reduction of B0 inhomogenei-
ties, reducing the effect of intra-renal fat, choice of spatial 
resolution, magnitude and number of echo times (TE) and 
control of respiratory motion.
Renal BOLD MRI in humans has been performed at 
both 1.5 and 3T in almost equal distribution to-date: of 79 
renal BOLD MRI human and animal studies included in a 
previous PARENCHIMA systematic review, 41 were per-
formed at 1.5T, 42 at 3T, and four used magnets of both field 
strengths [29]. Even though there was consensus (Table 7; 
100% of non-abstaining respondents, with 30% abstention 
rate) that 1.5T provides BOLD data of acceptable quality, 
there was a general preference for 3T over 1.5T (Table 4) 
(74% agreement). 3T has the known advantage of greater 
SNR, increased T2* weighting and hence higher R2* values. 
However, magnetic field inhomogeneities, bulk magnetic 
susceptibility (BMS) artifacts and fat-water chemical shift 
are also magnified at 3T [29]. Twenty percent of respond-
ents mentioned these disadvantages of 3T in imaging the 
kidney near complex abdominal structures like the bowel, 
when motivating their disagreement or hesitancy to agree 
with the statement that 3T was superior. For control of res-
piratory motion, consensus was reached already in Round 1 
(Table 7) that breath-holding is the best approach for both 
native kidneys and transplants (80%), although panelists who 
disagreed (20%) were familiar with or working on respira-
tory-triggered sequences.
There was consensus in Round 1 in choosing the smallest 
receiver bandwidth for the selected maximum TE (and num-
ber of echoes) in order to maximize SNR, and most respond-
ents (88%) thought that the number of echoes and spacing 
between TEs have an effect on data quality (Table 7). It 
was generally agreed that more acquired TEs can improve 
robustness of T2*/R2* fitting. Eight to sixteen echoes are 
commonly used in the literature to-date. Expert opinion was 
evenly split regarding choice of longest TE based on the 
longest T2* expected in the kidney (Table 4). While 53% of 
non-abstaining respondents tended to agree that the long-
est TE should be equal to the longest T2* there were con-
cerns that it may be too conservative (e.g. more data can be 
acquired beyond that value to improve the fit). Conversely, 
acquiring up to 1.5 times the longest T2* expected in renal 
tissue, while preferable to 53% of respondents, raised con-
cerns that the noise floor could be reached in tissues with 
low oxygenation, that the TR, and hence breath-hold inter-
val, would be increased too much, or that good image qual-
ity could not be obtained with some coils at TE = 1.5 times 
longest T2* expected in the kidney.
With regards to mitigating (or minimizing)  B0 inhomo-
geneities, most respondents (65%, Table 4) did not consider 
the standard abdominal shim performed by the scanner to be 
sufficient for quality BOLD data. There was overall consen-
sus that a restricted shim should be performed on a volume 
encompassing both kidneys (76% of all respondents, 91% 
of clinicians, but only 64% of physicists, agreed), but not 
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on a smaller volume encompassing each kidney separately 
(79% of all respondents, and 75% of physicists and 78% 
of clinicians, disagreed). The main concern with shimming 
on each kidney separately was the time consuming work-
flow (12.5% of respondents), strongly localized shimming 
introducing artifacts from outside the shimmed area (8% of 
respondents), while 1 respondent observed no difference in 
T2* maps between the kidneys when shimming for each kid-
ney separately. Respondents using BOLD in the study of kid-
ney transplants used saline bags placed over the skin at the 
location of the allograft to mitigate susceptibility artifacts 
from the allograft’s proximity to the body surface and from 
bowel gas [21, 23]. Respondents acknowledged that local-
ized shimming could not always address  B0 inhomogenei-
ties, which is why there was consensus that acquiring a 3D 
 B0 map is useful for quality control of BOLD data (80% of 
non-abstaining respondents, 78% of physicists, and 67% of 
clinicians agreed). Acquisition of many BOLD datasets with 
 B0 maps should also foster the development of widely avail-
able open-source post-processing software tools that correct 
the measured R2* by removing the effect of  B0 inhomogene-
ity facilitating multicentre studies. Among physicians 67% 
of non-abstaining respondents agreed on the question of the 
choice of  B0 map, and there was a high rate of abstaining 
answers (31–42%), which suggests a low availability or uti-
lization of  B0 mapping sequences and techniques on clinical 
scanners. However, a dual-echo GRE scheme to generate 
 B0 maps from the phase difference of the two echoes is now 
available on all MR vendors. It should be noted that there 
are no reports in the published literature yet to support these 
recommendations regarding shimming, which may explain 
the high rate of abstain responses.
One manifestation of  B0 inhomogeneity is the voxel-size 
dependence of R2* estimates [36]. There was evidence to 
show that slice thickness (usually larger than in-plane voxel 
size) contributed more to the observed effect [36]. The 
panelists were asked to consider this evidence [36] when 
responding to the last four items of the Acquisition portion 
of the survey (Table 4). While consensus was not achieved 
on the need for a nearly isotropic resolution, a sizeable por-
tion of non-abstaining respondents (67%) thought isotropic 
voxels were preferred for imaging an organ with complex 
structures like the kidney. However, isotropic imaging raised 
concerns because of the need to match voxels in multi-par-
ametric protocols with other MRI contrasts that are not best 
suited to an isotropic resolution protocol, such as arterial 
spin labeling (ASL). There was consensus for using 3 × 
3 mm2 in-plane resolution (not necessarily isotropic). Simi-
larly consensus was reached for using acceleration factor of 
2 to achieve anatomical coverage within a breath-hold while 
maintaining sufficient SNR.
Studies in the liver demonstrate that the presence of fat 
can influence T2*/R2* measurements [37]. While healthy 
kidneys do not contain intra-renal fat, in some diseased 
states such as diabetes [38] and obesity [39], there may be 
intra-renal fat present. For this and other reasons (delinea-
tion of kidney), fat saturation/water excitation is desirable 
for BOLD MRI acquisitions, but not widely used. The low 
utilization of these techniques is reflected in the response 
to the question of whether it is preferable to control for the 
presence of fat by selection of all echo times with fat-water 
in phase rather than by performing fat saturation (71% agree-
ment, 42% abstain rate). The statement reached agreement 
among physicists (78%), but not among clinicians (50/50% 
split, with 38–54% abstain rate). Because of the lack of con-
sensus, but tendency towards a choice of in-phase fat-water 
TEs, we recommend performing both fat saturation/suppres-
sion and choosing in-phase TEs.
Data analysis
The results of the survey items on data analysis are sum-
marized in Tables 5 and 7. 100% of respondents agreed that 
the reported value should be R2* (rather than T2*) obtained 
from exponential or log-linear fit of BOLD signal (83%). 
However, respondents cautioned that the results are not com-
parable between fitting methods, and that the log-linear fit 
increases the influence of noise for later echoes with low 
SNR. A possible solution to correcting for noise at later 
echoes is to use a weighted log-linear fit. An exponential fit 
should also be corrected for noise, after identifying the noise 
floor. Of course, this concern can be mitigated by limiting 
the maximum TE to be ~ T2* of tissue of interest.
In Round 1, respondents reached consensus that measur-
ing R2* values in both the cortex and medulla is equally 
important (Table 7; 90%). Early renal BOLD MRI research 
was driven by the low oxygenation and greater sensitivity 
to changes in oxygen demand in the medulla. Some stud-
ies recommended the medulla-to-cortex ratio in R2* to be a 
more sensitive marker especially in diabetes, taking advan-
tage of the disparate changes with disease severity in cor-
tex vs. medulla [14]. Increased R2* in the cortex has been 
observed in chronic kidney disease (CKD) [19], with either 
minimal change or actually a reduction in medullary R2* 
[15, 40, 41]. The consensus among all respondents (Table 5; 
82%) was that a novice BOLD researcher can obtain R2* 
measurements in both cortex and medulla using regions of 
interest (ROIs) drawn in collaboration with a radiologist. R2* 
measurements in this case can be based on average signal in 
the ROI (for protocol optimization), or pixel-based within 
the ROIs. Ideally, manual ROIs should delineate as much of 
the cortex and medulla as possible, avoiding lesions, large 
vessels and fat.
More than with image acquisition, there was greater dif-
ficulty in obtaining consensus on advanced, semi-automatic 
image analysis methods. This is due to the lack of availability 
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and experience with each method beyond the proponent site. 
Among advanced methods of ROI segmentation, semi-auto-
mated segmentation of cortex and medulla using histogram 
analysis to define masks for cortex and medulla based on T1 
maps [42] nearly reached consensus among 72% of respond-
ents (75% of clinicians, 70% of physicists). Histogram anal-
ysis of T2*/R2* maps and the 12-layer concentric objects 
(TLCO) or “onion peel” method [19] generated a 50/50 split 
in preferences among respondents. There was agreement 
among physicists (75%), but not among clinicians (50–50% 
split of opinion) that semi-automated analysis methods, 
which identify pixels as being “hypoxic” based on a pre-
determined threshold value for R2* [28], are not preferred. 
Concerns regarding implementation, as it is difficult (if not 
impossible, given the effects of shimming) to decide on a 
reliable threshold for hypoxia for the condition or patient 
population studied. Some common concerns expressed by 
respondents regarding semi-automated segmentation meth-
ods were that segmentation software packages are not widely 
available, have been tested only with particular acquisition 
protocols (e.g. preference for true coronal to the kidney ori-
entation for the TLCO method [19]), may not work so well 
in diseased kidneys with poor cortico-medullary differentia-
tion, and have not been validated across sites.
Application and interpretation
The results of the survey items on BOLD applications and 
data interpretation are summarized in Tables 6 and 7. In 
Round 1 (Table 7), consensus (80%) was achieved among 
respondents that renal BOLD MRI can reflect oxygenation 
qualitatively, as the confounding factors of perfusion, blood 
volume fraction (per tissue volume), hematocrit, and shifts 
of the oxy-Hb dissociation curve preclude it from being 
truly quantitative. For that reason, respondents consented 
to the statements that renal BOLD MRI is more suited to 
detect changes in renal oxygenation within the same kidney 
rather than for comparing cohorts (88%), and that examin-
ing changes in R2* brought on by a furosemide challenge is 
useful, although not necessary for all applications (75%).
The consensus statement emerging from Round 1 that 
BOLD MRI provides a relative measure of oxygen availa-
bility, rather than an absolute measure of oxygenation, was 
supported in Round 2 (Table 6; 87% of respondents). The 
consensus from Round 1 that BOLD MRI is a potentially 
prognostic technique (100% non-abstaining respondents) 
was further improved in Round 2, with 78% of respond-
ents (Table 6) considering BOLD a potentially diagnostic 
technique. There was notable split among clinicians (92%) 
and physicists (63%) on the diagnostic value of BOLD. 
The statement that BOLD MRI is currently only useful 
as a research tool (Table 6) narrowly missed the consen-
sus threshold with 74% overall. Respondents commented 
that BOLD can only be diagnostic in combination with 
other methods, due to the confounding factors, and that 
its clinical impact has to be better demonstrated beyond a 
few experienced centers.
Among applications of BOLD MRI, the consensus 
(Table 6; 86% overall) emerged that renal BOLD MRI is 
best suited for studying acute responses to physiological 
or pharmacological maneuvers (e.g. water or furosemide 
challenge). Fewer respondents considered renal BOLD 
suitable for evaluation of acute dysfunction in native kid-
neys or allografts (67% overall, 75% of physicists, 60% 
of clinicians) or chronic renal dysfunction (53% overall, 
44% physicists, 60% clinicians). Although there are studies 
showing differences between groups in acute dysfunction 
[43, 44], respondents (8%) commented there are better 
ways to assess renal dysfunction, and that more work is 
needed to show clinical relevance of BOLD MRI (8%). 
The division in opinion on the utility of BOLD in CKD 
is based on the published studies, which found increased 
R2* (lower oxygenation) [14, 45] or decreased R2* [15] 
in patients with CKD compared to controls, and did not 
show a significant correlation of R2* with estimated GFR 
or CKD stage [35, 40, 46].
With regards to short and long-term scan-rescan repeat-
ability, the consensus among respondents (85%) was that the 
literature [47, 48] shows high repeatability for translational 
research, within the same site, if shimming and physiologi-
cal conditions (diet, hydration) are controlled. However, 
68% of respondents disagreed that multi-center repeatability 
suitable for clinical trials has been shown in the literature 
to-date. Respondents commented that standardization of pro-
tocols and more accumulation of results from multi-center 
studies is needed.
Issues reaching consensus
Most items that did not reach consensus are related to split 
opinions in the literature, or limited data available to-date. 
The fact that our respondents did not reach consensus on 
superiority of imaging at 3T, standardizing diet, or salt 
intake reflects the even split among published studies: stud-
ies at 1.5T and 3T are equally represented in the literature, 
and a minority of published studies have standardized salt 
intake [29]. Split opinion on the longest TE is also due to a 
lack of systematic comparison studies exploring how feasi-
ble it is to image at long TE’s (1× or 1.5 x T2* of cortex) on 
different platforms, with respondents relying on their indi-
vidual experience. More than with image acquisition, there 
was greatest difficulty in obtaining consensus on advanced, 
semi-automatic image analysis methods. This is due to the 
lack of availability and experience with each method beyond 
the proponent site.
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Limitations
The panel of experts that participated in this consensus for-
mation process was of a relatively small size (n  = 24). How-
ever, it included an equal proportion of clinical and techni-
cally oriented scientists from groups that have all developed 
or applied renal BOLD MRI. Given the small sample size, 
we did not record other factors that may influence responses, 
such as respondents’ age, years of experience in BOLD MRI, 
and location by country. In future recommendation surveys 
and papers, we plan to account for how these factors influ-
ence the recommendations. Although consensus emerged 
for acquisition methods, the greatest variability of responses 
covered analysis and interpretation of data, particularly 
semi-automatic segmentation of BOLD MRI cortical and 
medullary data, since only a limited number of dedicated 
research groups have experience with the advanced analysis 
methods.
Remaining challenges for future research
The unresolved issues emerging from this consensus process 
point to potential avenues for future research. More system-
atic studies are needed on whether controlling diet beyond 
a 4-h fast before the scan through standardized diet and salt 
intake has an effect on renal BOLD MRI. Technical develop-
ment, validation and dissemination is needed for  B0 mapping 
and related methods to mitigate  B0 inhomogeneities and bulk 
susceptibility artifacts. Similarly, respiratory motion control 
by breath-holding is a limiting factor, creating a trade-off 
between the number of echo times or slices acquired, which 
can be addressed by further development of fast free-breath-
ing BOLD MRI sequences or respiratory motion correction 
methods. Respiratory motion control beyond breath-holding 
is essential for achieving whole kidney coverage in BOLD 
MRI acquisitions.
On the data analysis side, the survey responses underline 
the need for dedicated renal BOLD MRI post-processing 
software to facilitate semi-automated image analysis, with 
validation and dissemination of the software beyond the 
most experienced sites. The development and validation of 
(semi-)automatic segmentations methods for renal BOLD 
MRI data should be encouraged, especially in patient popu-
lations with poor cortico-medullary differentiation, where 
manual selection of cortical and medullary ROIs can be 
biased.
There is a future role for artificial neural networks/ arti-
ficial intelligence (AI) in solving cortex and medulla seg-
mentation problems on BOLD MRI data acquired in patients 
with renal disease. To date, there are no published studies on 
AI in renal BOLD MRI, but artificial neural networks have 
been used in the brain for quantitative analysis of BOLD 
MRI and quantitative susceptibility mapping data [49]. 
AI methods have been used for automatic segmentation of 
the cortex and medulla for renal volumetry based on T1-
weighted imaging, with [50] and without gadolinium con-
trast enhancement [51–53]. The ROIs obtained by automatic 
segmentation of  T1-weighted images can inform segmenta-
tion of the cortex and medulla in a multiparametric MRI 
protocol. We plan to include a literature review as the field 
develops, and survey questions on AI in renal BOLD MRI in 
future iterations of the recommendations. Use of AI requires 
large training sets of manually annotated, high-quality renal 
BOLD MRI data, with robust clinical validation and cor-
relation with patient-centric outcomes [54]. Increased qual-
ity and standardization in data acquisition is thus needed 
for the large-scale deployment of AI in renal BOLD MRI. 
Multicenter studies with harmonized scanning protocols, 
uniform semi-automatic data analysis, and the development 
of a phantom with reference cortical and medullary R2* val-
ues are high priority for the qualification of BOLD MRI R2* 
as a renal biomarker. Additional challenges are also likely 
to emerge with better understanding of the kidney’s com-
plex physiology and pathophysiology, such as the degree to 
which renal functional markers are influenced by the huge 
range of drugs used to treat renal and systemic diseases, 
as well as how these measured renal parameters change in 
multi-morbidity states.
Conclusion
This collaborative effort was undertaken with the aim of 
putting forward technical recommendations for facilitating 
the more widespread use of renal BOLD MRI protocols for 
clinical research and hopefully their eventual translation to 
the clinical setting. Based on the current literature and using 
a modified Delphi method to seek consensus, we have devel-
oped a set of recommendations for renal BOLD MRI data 
collection. The recommendations are to be considered as 
guidelines to motivate translation and multi-center studies. 
Given the dynamic nature of physiological imaging meth-
ods, techniques are bound to evolve, especially in terms of 
data acquisition and analysis of renal BOLD MRI. There-
fore, we expect and encourage periodic updates of these 
recommendations.
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